Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
1,288,660
-
Shares change
-
+6,889
-
Total reported value, excl. options
-
$4,173,419
-
Value change
-
+$25,707
-
Number of buys
-
7
-
Number of sells
-
7
-
Price
-
$3.24
Institutional Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q4 2023
As of 31 Dec 2023 Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) had 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,288,660 shares of stock of the company.
Largest 10 holders included BANK OF AMERICA CORP /DE/, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, EDGEWOOD MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Qube Research & Technologies Ltd, BlackRock Inc., and NORTHERN TRUST CORP.
This table shows 26 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.